by The global optical genome mapping market has witnessed significant growth over the past few years owing to increasing R&D investments in genome analysis and services. Optical genome mapping helps in detecting structural variations in DNA through high-resolution, single-molecule imaging without breaking the DNA molecules. It maps DNA fragments without gene sequencing and produces high-resolution images of intact chromosomes by taking pictures of individual DNA molecules labeled with fluorescent probes. The technology is useful in disease research, discovery of disease-causing mutations, cancer research, personalized medicine development, and more.
The Global Optical Genome Mapping Market is estimated to be valued at US$ 109.9 MN in 2024 and is expected to exhibit a CAGR of 21.% over the forecast period 2024 To 2031.
Key Takeaways
Key players operating in the global Optical Genome Mapping Market are Bionano Genomics, Nucleome Informatics Private Limited, Praxis Genomics, LLC, SourceBio International Limited (Source BioScience), MedGenome, INRAE (French Plant Genomic Resources Center (CNRGV)), PerkinElmer (PerkinElmer Genomics), Genohub Inc., Hofkens Lab, and Cerba.
Key opportunities in the market include increasing R&D in genomics, rising adoption of Optical Genome Mapping in cancer research and clinical diagnostics, and growing funding and initiatives for genomics research worldwide. Advancements like whole-genome mapping at high resolution, faster mapping without sequencing, and integration with other omics technologies are fueling market growth.
Technological advancements like single-cell optical genome mapping, combined mapping and sequencing techniques, high-throughput mapping platforms, and automation are expanding the applications of optical genome mapping. Integration with AI and machine learning is helping in advanced genome data analysis.
Market drivers
The increasing focus on precision medicine and personalized therapeutics is a major market driver. Optical genome mapping helps in disease diagnostics, treatment strategies, drug development, and clinical trials based on an individual’s genome. Rising genome research activities for understanding genetic disorders and rare diseases are also propelling the demand. Growing genomics applications in preimplantation genetic testing, livestock breeding, and forensics are fueling the optical genome mapping market growth.
Current Challenges in Global Optical Genome Mapping Market
The optical genome mapping market has been witnessing significant technological advancements such as the development of single-molecule and Bionano data analysis tools. However, it still faces some challenges associated with data management, storage, and interpretation. Complex genome architecture poses challenges in genome mapping analysis and visualization. Data integration from genome mapping with other omics data is still a major challenge. The applications of optical genome mapping are also limited due to high capital investment and running costs. There is a need for improved cost-effective devices capable of high throughput and better resolution. Development of standard platforms, protocols, and genome maps libraries is necessary for widespread clinical adoption.
SWOT Analysis
Strength: Provides high resolution, long range genome mapping. Enables direct visualization of structural variations.
Weakness: Requires complex and expensive instrumentation. Data analysis and interpretation is challenging.
Opportunity: Potential applications in disease research, drug development and precision medicine. Growing investments and funding for genomics and sequencing.
Threats: Highly competitive market. Threat from emerging low cost sequencing technologies. Regulatory and ethical issues associated with clinical genomics.
Geographical Regions
North America dominated the global optical genome mapping market in terms of value share in 2024, due to increasing focus on genomic research for cancer and other diseases. Asia Pacific is estimated to witness the fastest growth during the forecast period supported by growing genomics funding, rising healthcare expenditure and increasing awareness.
The optical genome mapping market in China is expected to exhibit robust growth owing to expanding biotech sector, strong government support for life science research and growing collaboration with global players. Japan also represents a significant opportunity attributed to increasing R&D investment on precision and regenerative medicine by industry and government.
Note:
1. Source: Coherent Market Insights, Public sources, Desk research.
2. We have leveraged AI tools to mine information and compile it.
